Abstract
Background: Previous work has shown that teratogens such as hyperthermia (HS), 4-hydroperoxycyclophosphamide (4CP), and staurosporine (ST) induce cell death in day 9 mouse embryos by activating the mitochondrial apoptotic pathway. Key to the activation of this pathway is the activation of a caspase cascade involving the cleavage-induced activation of an initiator procaspase, caspase-9, and the downstream effector procaspase, caspase-3. For example, procaspase-3, an inactive proenzyme of 32 kDa is cleaved by activated caspase-9 to generate a large subunit of approximately 17 kDa and a small subunit of approximately 10 kDa. In turn, caspase-3 is known to target a variety of cellular proteins for proteolytic cleavage as part of the process by which dying cells are eliminated. Previous work has also shown that neuroepithelial cells are sensitive to teratogen-induced activation of this pathway and subsequent cell death whereas cells of the heart are resistant. Although caspase-3 is a key effector caspase activated by teratogens, two other effector caspases, caspase-6 and caspase-7, are known; however, their role in teratogen-induced cell death is unknown. Methods: Because cleavage-induced generation of specific subunits is the most specific assay for activation of caspases, we have used antibodies that recognize the procaspase and one of its active subunits and a Western blot approach to assess the activation of caspase-6 and caspase-7 in day 9 mouse embryos (or heads, hearts and trunks isolated from whole embryos) exposed to HS, 4CP, and ST. To probe the relationship between teratogen-induced activation of caspase-9/caspase-3 and the activation of caspase-6/caspase-7, we used a mitochondrial-free embryo lysate with or without the addition of cytochrome c, recombinant active caspase-3, or recombinant active caspase-9. Results: Western blot analyses show that these three teratogens, HS, 4CP, and ST, induce the activation of procaspase-6 (appearance of the 13 kDa subunit, p13) and caspase-7 (appearance of the 19 kDa subunit, p19) in day 9 mouse embryos. In vitro studies showed that both caspase-6 and caspase-7 could be activated by the addition of cytochrome c to a lysate prepared from untreated embryos. In addition, caspase-6 could be activated by the addition of either recombinant caspase-3 or caspase-9 to a lysate prepared from untreated embryos. In contrast, caspase-7 could be activated by addition of recombinant caspase-3 but only minimally by recombinant caspase-9. Like caspase-9/caspase-3, caspase-6 and caspase-7 were not activated in hearts isolated from embryos exposed to these three teratogens. Conclusions: HS, 4CP and ST induce the cleavage-dependent activation of caspase-6 and caspase-7 in day 9 mouse embryos. Results using DEVD-CHO, a caspase-3 inhibitor, suggest that teratogen-induced activation of caspase-6 is mediated by caspase-3. In addition, our data suggest that caspase-7 is activated primarily by caspase-3; however, we cannot rule out the possibility that this caspase is also activated by caspase-9. Finally, we also show that teratogen-induced activation of caspase-6 and caspase-7 are blocked in the heart, a tissue resistant to teratogen-induced cell death.
Similar content being viewed by others
References
Adams JM, Corey S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–5.
Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev. 1998;8:55–62.
Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res. 2000;256:50–7.
Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998;12:1551–70.
Datta SR, Dudek H, Tao X. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231–41.
Datta SR, Katsov A, Hu L. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell. 2000;6:41–51.
Du C, Fang M, Li Y, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation during apoptosis. Cell. 2000;102:33–42.
Dunty WC, Chen S-Y, Zucker RM, Dehart DB, Sulik KK. Selective vulnerability of embryonic cell populations to ethanol-induced apoptosis: implications for alcohol-related birth defects and neurodevelopmental disorder. Alcohol Clin Exp Res. 2001;25:1523–35.
Gao X, Blackburn MR, Knudsen TB. Activation of apoptosis in early mouse embryos by 2′-deoxyadenosine exposure. Teratology 1994;49:1–12.
Gross A, Yin X-M, Wang K, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas Death. J Biol Chem. 1999;274:1156–63.
Hakem R, Hakem A, Duncan GS, et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 1998;94:339–52.
Jurgensmeier JM, Xie Z, Deveroux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998;95:4997–5002.
Kharbanda S, Pandey P, Schofield L, et al. Role for bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA-damage-induced apoptosis. Proc Natl Acad Sci USA 1997;94:6939–42.
Kim CN, Wang X, Huang Y, et al. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 1997;57:3115–20.
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132–6.
Knudsen TB. Cell death. In: RJ Kavlock, GP Daston, eds. Drug toxicity in embryonic development I, volume 124/I. Springer. 1997:211–44
Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 1996;384:368–72.
Kuida K, Haydar TF, Kuan C-Y, et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 1998;94:325–52.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;27:680–5.
Little SA, Mirkes. Teratogen-induced activation of caspase-9 and the mitochondrial apoptotic pathway in early postimplantation mouse embryos. Toxicol Appl Pharmacol. 2002;181:142–51.
Menkes B, Sandoe S, Ilies A. Cell death in teratogenesis. In: Woollam DH, ed. Advances in teratology. Academic Press, New York, 1970:169–215.
Milaire J, Rooze M. Hereditary and induced modifications of the normal necrotic patterns in the developing limb buds of the rat and mouse; facts and hypotheses. Arch Biol (Bruxelles) 1983;94:459–90.
Mirkes PE. Effects of acute exposures to elevated temperatures on rat embryo growth and development in vitro. Teratology 1985;32:259–66.
Mirkes PE, Little SA. Teratogen-induced cell death in post-implantation mouse embryos: differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differen. 1998;5:592–600.
Mirkes PE, Little SA. Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine. Toxicol Appl Pharmacol. 2000;162:197–206.
Mirkes PE. Warkany Lecture. To die or not to die, the role of apoptosis in normal and abnormal development. Teratology. 2002;65:228–39.
New DAT. Whole embryo culture and the study of mammalian embryos during organogenesis. Biol Rev. 1978;53:81–122.
Scott WJ. Cell death and reduced proliferative rate. In: JG Wilson, FC Fraser, eds. Handbook of teratology. Volume 2. Plenum. 1977:81–98.
Shepard TH. Catalog of teratogenic agents, 10th edn. The Johns Hopkins University Press, Baltimore, 2001.
Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002;9:459–70.
Slee EA, Adrain C, Martin SJ. Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 1999;6:1067–74.
Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem. 2000;69:217–45.
Sulik KK, Cook CS, Webster WS. Teratogens and craniofacial malformations: relationships to cell death. Development. 1988;103(Suppl):213–32.
Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397:441–6.
Thayer JM, Mirkes PE. Programmed cell death and N-acetoxy-2-acetylaminofluorene-induced apoptosis in the rat embryo. Teratology. 1995;51:418–29.
Umpierre CC, Little SA, Mirkes PE. Co-localization of active caspase-3 and DNA fragmentation (TUNEL) in normal and hyperthermia-induced abnormal mouse development. Teratology. 2001;63:134–43.
Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000;102:43–5.
Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139:1281–92.
Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129–32.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Little, S., Kim, W. & Mirkes, P. Teratogen-induced activation of caspase-6 and caspase-7 in early postimplantation mouse embryos. Cell Biol Toxicol 19, 215–226 (2003). https://doi.org/10.1023/B:CBTO.0000003828.61418.d4
Issue Date:
DOI: https://doi.org/10.1023/B:CBTO.0000003828.61418.d4